טוען...
Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation
Hemoglobinopathies are among the most common monogenic diseases worldwide. Approximately 1–5% of the global population are carriers for a genetic thalassemia mutation. The thalassemias are characterized by autosomal recessive inherited defects in the production of hemoglobin. They are highly prevale...
שמור ב:
| הוצא לאור ב: | Drugs |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer International Publishing
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7299245/ https://ncbi.nlm.nih.gov/pubmed/32557398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-020-01341-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|